P-21 Protocol
Dosing & Research
Last Updated: September 4, 2026
Neuroprotection, Neurogenesis and BDNF-linked research, Cognition/memory studies, Alzheimer-related models
Half-Life
Not Well Characterized
Administration
Intranasal
Frequency
1-2x daily
How It Works
- Neuroprotection
- Neurogenesis and BDNF-linked research
- Cognition/memory studies
- Alzheimer-related models
Dosing Structure
Dose
500 mcg - 1 mg
Frequency
1-2x daily
Notes
Break: 2-4 weeks between cycles.
Example Protocols
Dose: 500 mcg - 1 mg
Frequency: 1-2x daily
Duration: 4-6 weeks
Off Period: Not listed
Find Research Grade P-21
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
•
Break: 2-4 weeks between cycles.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.